This site or third-party tools used by this make use of cookies necessary for the operation and useful for the purposes described in the cookie policy. By clicking on "I accept" you consent to the use of cookies.

Treatment of severe acute asthma, adrenaline and cortisone

  1. Gastroepato
  2. Pneumology
  3. Treatment of severe acute asthma
  4. Respiratory system
  5. Bronchial asthma
  6. Allergic rhinitis
  7. Current asthma guidelines

notes by  dr Claudio Italiano

Signs and symptoms of severe asthma

The patient reaches his attention in the grip of a severe asthmatic crisis. When I was writing, as a young man, at the dawn of his career, he had to treat a patient in severe, cyanotic, confused bronchospasm, in a state of collapse.

The patient presented:

•  Cyanosis
• Tachypnea
• Tachycardia
• Respiratory silence
• Collapse
• He could not express himself
• he was doing gestures

At that time it was necessary to give the patient oxygen with a mask of Bossignauc at positive pressure and high flow, adrenaline for aerosol and adrenaline subcutaneous, obviously diluted, high dose cortisone (see below), theophylline, beta 2 agonists for aerosols and ipatropium bromide.

Why severe asthma?

When we breathe, the air goes down through the trachea, which then divides into two smaller tubes, the bronchi. The bronchial tubes allow air to reach the lungs and, once inside the lungs, they are divided into many small tubes (the bronch́oli), which resemble the branches of a tree.

The walls of all the airways up to the lungs are covered by several layers of muscles, able to contract and change the width of their caliber. If a person suffers from asthma, his airways become periodically narrower than normal.

 This means that there is less space for air entering and leaving and therefore it is harder to breathe. Moreover the bronchial mucosa goes into edema, mucus is produced and this aggravates the respiratory picture.

 The patient of our clinical case, after about an hour of intensive care, recovered from the crisis and was therefore not intubated by the resuscitator (see resuscitation). Most severe seizures develop within a period of 6 hours or more (most often over 48 hours), allowing the patient and healthcare personnel to take effective action.

When the patient arrives at the observation affected by an asthmatic crisis, the clinical signs and symptoms must be noted and it is necessary to proceed with the implementation of objective clinical measures. Clinical measurements such as PEF or FEV1 (expressed as a percentage of the best personal value) and oxygen saturation must be reported. The saturimetry determines the adequacy of oxygen therapy and the need for arterial blood gas analysis (see acid-base balance).

 The goal of oxygen therapy is to maintain Sp02> 92%. Preprinted forms can be a useful tool to perform a systematic initial assessment of asthma severity. The BTS / SIGN guidelines (the British Thoracic Society - BTS and the Scottish Intercollegiate Guidelines Network - SIGN) to establish the severity of asthma during a crisis. (see also the treatment of asthma)

Severity of asthma

Potentially lethal asthma (PEF <33% of the best personal value)
• Organize immediate hospitalization
• Administer  oxygen at 40-60%
• Administration of steroids: prednisolone 40-50 mg or hydrocortisone 100 mg e.v.
• Administer bronchodilators preferably with nebuliser - salbutamol 5 mg or terbutaline 10 mg - and ipratropium bromide 0.5 mg. (In the absence of a nebuliser deliver
• Beta2agonist puff by spacer, repeated 10-20 times)

Characteristics of asthma

Severity Features  
Potentially lethal asthma PEF <33% of the theoretical or of the
best personal value
Sp02 <92%
Pa02 <60 mmHg
PaC02 normal
(35-45 mmHg)
Respiratory silence
Cyanosis
Low respiratory efforts
bradycardia
Arrhythmia
Hypotension
Muscle exhaustion
Confusion
Coma
Severe acute asthma PEF 33-50% of the theoretical or of the best personal value
Respiratory rate> 25 apm
Heart rate> 110 bpm
Inability to complete sentences with only one breath
Moderate asthma Aggravating symptoms, PER 50-75% of the theoretical of greater personal value
Absence of features of severe acute asthma
Unstable asthma

 Type 1

Wide variability of PEF (daytime variability> 40% for> 50% of the time
over a period> 150 days) despite intensive treatment

Severe acute asthma (PEF 33-50% of the best personal or theoretical value)

• Consider hospitalization
• Administer  oxygen at 40-60%
• Administer bronchodilators preferably with nebuliser - salbutamol 5 mg or terbutaline 10 mg-and ipratropium bromide 0.5 mg (in the absence of a nebulizer, deliver 1 puff of Beta 2 agonist by spacer, repeated 10-20 times)
 •Administer steroids: prednisolone 40- 50 mg or hydrocortisone 100 mg ev In the absence of an answer, admit to the hospital

Moderate asthma

• Administer bronchodilators preferably with nebuliser - salbutamol 5 mg or terbutaline 10 mg (in the absence of a nebulizer, deliver 1 puff of Beta2 agonist by means of a spacer, repeated 10-20 times)
• If PEF is 50-75% of theoretical / best personal value, administer prednisolone 40-50 mg
• Continue or enhance the usual treatment

Treatment of asthmatic crises in adults

Pregnancy

•Administer oxygen immediately, maintaining saturation above 95% to prevent maternal and fetal hypoxia

Provide immediate hospitalization in case of severe or potentially lethal asthma. Administer drugs at the same dosages used outside of pregnancy. Provide hospitalization in case of one or more features of severe or life-threatening asthma, or if the patient reports a previous life-threatening crisis.

 In the case of an acute attack, an oral steroid dose should be administered as early as possible (40-50 mg of prednisolone in the adult, 30-40 mg of soluble prednisolone in the child over 5 years of age, 20 mg of soluble prednisolone in children aged 2 to 5 years) and thereafter for at least 5 days or until clinical improvement.

 Furthermore, as soon as possible it is necessary to administer high doses of Beta2-agonists by means of a spacer (10-20 puffs in adults, 10 puffs in children aged 2 to 5 years with severe seizures or 2-4 puffs in children aged between 2 and 5 years with moderate crisis). In case of inadequate response to treatment, continuous doses of Beta2-agonists should be given at intervals of 15-30 minutes.

 All patients with severe acute asthma should be treated with high-flow oxygen (Beta2-agonist nebulisations should be performed with oxygen-activated or compressed-air devices), except for patients with COPD, in which case it is more indicated the compressed air nebulization.

Hospital admission: indications

Immediate admission is necessary for patients with life-threatening asthma and for patients with severe acute asthma who do not respond to emergency treatment. Pregnant women with severe asthma or life-threatening asthma should also be treated in the hospital setting, and hospitalization must be immediate.

Hospital admission should also be considered in patients who come to the observation with severe acute asthma, in those with a history of previous serious incidents, in the attacks that occur in the afternoon or in the evening, in case of recent nocturnal symptoms or in the presence of elements of concern related to the patient's psychosocial circumstances.

 In acute asthma during pregnancy, oxygen should be administered immediately, in order to maintain arterial saturation over 95% and prevent both maternal and fetal hypoxia. Pregnant patients should be sent to the hospital immediately and the drugs can be administered at the same dosages used in non-pregnant patients.

Follow up

All patients with acute asthma should be re-evaluated within 48 hours of discharge from the hospital (or within 48 hours of emergency treatment if they are not hospitalized).
On this occasion it is necessary:
• Monitor symptoms and PEF
• Check the patient's inhalation technique
• Change treatment according to the guidelines for chronic asthma
• Persistent
• Provide a written intervention plan
• Eliminate potentially preventable triggering factors.


to learn more>>

Bronchial asthma
Allergy and allergens

Pneumology